T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$2.42B |
| 2 |
Wynn Resorts
WYNN
|
+$992M |
| 3 |
Eli Lilly
LLY
|
+$964M |
| 4 |
Visa
V
|
+$700M |
| 5 |
American Airlines Group
AAL
|
+$626M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PepsiCo
PEP
|
+$1.24B |
| 2 |
Dollar Tree
DLTR
|
+$1.13B |
| 3 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$1.03B |
| 4 |
Gilead Sciences
GILD
|
+$792M |
| 5 |
ROC
ROCKWOOD HLDGS INC
ROC
|
+$788M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.72% |
| 2 | Consumer Discretionary | 13.88% |
| 3 | Financials | 12.99% |
| 4 | Industrials | 12.02% |
| 5 | Technology | 9.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1276
Cincinnati Financial
CINF
$26.6B
| $11.2M | ﹤0.01% |
237,509
| – | – |
|
1277
Genworth Financial
GNW
$3.83B
| $11M | ﹤0.01% |
841,100
+14,000
| +2% | +$202K |
|
|
GAS
1278
DELISTED
AGL Resources Inc
GAS
| $11M | ﹤0.01% |
214,116
| – | – |
|
1279
Marriott Vacations Worldwide
VAC
$4.19B
| $10.9M | ﹤0.01% |
172,268
+93,200
| +118% | +$5.52M |
|
|
HZNP
1280
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $10.9M | ﹤0.01% |
884,100
-5,900
| -0.7% | -$68.6K |
|
|
KYTH
1281
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
| $10.9M | ﹤0.01% |
331,213
+10,935
| +3% | +$385K |
|
|
COHR
1282
DELISTED
Coherent Inc
COHR
| $10.8M | ﹤0.01% |
176,800
-4,700
| -3% | -$296K |
|
1283
Goodyear
GT
$1.76B
| $10.8M | ﹤0.01% |
478,396
-4,410
| -0.9% | -$113K |
|
|
TGNA
1284
DELISTED
TEGNA Inc
TGNA
| $10.7M | ﹤0.01% |
691,562
+10,131
| +1% | +$174K |
|
1285
Nabors Industries
NBR
$1.38B
| $10.7M | ﹤0.01% |
9,432
+1,222
| +15% | +$1.63M |
|
|
MTCN
1286
DELISTED
ARCELORMITTAL 6% MANDATORILTY CONV SUB NT DUE 2016 (LUX)
MTCN
| $10.7M | ﹤0.01% |
506,392
+20
| +0% | +$447 |
|
1287
iShares Russell 2000 Value ETF
IWN
$14.7B
| $10.6M | ﹤0.01% |
113,710
-710,140
| -86% | -$70.3M |
|
1288
Howard Hughes
HHH
$3.98B
| $10.6M | ﹤0.01% |
74,191
-82,556
| -53% | -$12.1M |
|
|
ESL
1289
DELISTED
Esterline Technologies
ESL
| $10.6M | ﹤0.01% |
94,890
-2,500
| -3% | -$285K |
|
|
EIGR
1290
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $10.5M | ﹤0.01% |
+2,237
| New | +$11.8M |
|
|
ADT
1291
DELISTED
ADT Corp
ADT
| $10.5M | ﹤0.01% |
295,831
-35,400
| -11% | -$1.25M |
|
1292
Clarus
CLAR
$140M
| $10.5M | ﹤0.01% |
1,390,815
-172,433
| -11% | -$1.54M |
|
|
ACOR
1293
DELISTED
Acorda Therapeutics
ACOR
| $10.5M | ﹤0.01% |
2,572
+3
| +0.1% | +$11.3K |
|
|
AERI
1294
DELISTED
Aerie Pharmaceuticals
AERI
| $10.4M | ﹤0.01% |
+502,224
| New | +$9.9M |
|
|
ECHO
1295
EchoStar
ECHO
$26.5B
| $10.4M | ﹤0.01% |
262,748
+33,811
| +15% | +$1.39M |
|
|
BGC
1296
DELISTED
General Cable Corporation
BGC
| $10.3M | ﹤0.01% |
684,650
-967,442
| -59% | -$21.2M |
|
|
FRF
1297
DELISTED
FORTEGRA FINL CORP COM STK (DE)
FRF
| $10.3M | ﹤0.01% |
1,043,966
-723,020
| -41% | -$6.32M |
|
|
KW
1298
DELISTED
Kennedy-Wilson Holdings
KW
| $10.3M | ﹤0.01% |
429,143
+150,300
| +54% | +$3.79M |
|
1299
Darden Restaurants
DRI
$25.4B
| $10.2M | ﹤0.01% |
222,678
+559
| +0.3% | +$23.6K |
|
1300
MaxLinear
MXL
$7.38B
| $10.1M | ﹤0.01% |
1,473,930
-140,387
| -9% | -$1.26M |
|
Similar funds
T. Rowe Price Associates's Q3 2014 Portfolio in Review
As of Q3 2014, T. Rowe Price Associates held 2,614 positions worth $458B, down 1% from $463B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q3 2014 filing shows 88 new, 949 increased, 837 reduced and 73 closed positions. Its largest new stake was Alibaba: 26,922,443 shares worth $2.39B. The largest sale was PepsiCo, an estimated $1.24B.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q3 2014 buy was Alibaba: 26,922,443 shares worth $2.39B.
- T. Rowe Price Associates added most to Wynn Resorts in Q3 2014, an estimated $992M increase.
- T. Rowe Price Associates's biggest Q3 2014 reduction was PepsiCo, cutting an estimated $1.24B.
- T. Rowe Price Associates fully exited ROCKWOOD HLDGS INC in Q3 2014, selling an estimated $788M.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $458B portfolio in Q3 2014.
- T. Rowe Price Associates opened 88 new positions and closed 73 in Q3 2014.
- T. Rowe Price Associates's portfolio value fell 1% quarter-over-quarter to $458B.
Based on T. Rowe Price Associates's 13F filing for Q3 2014, filed 14 Nov 2014.